Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Theravance cuts 17% of staff, JAK inhibitor program
3 years ago
People
R&D
Decades after breakthrough, scientists still puzzling over mRNA delivery
3 years ago
R&D
In Focus
Suffering CNS player flips another losing hand in a last PhII gamble and calls for the axe
3 years ago
R&D
AstraZeneca expands Canada R&D work, to add 500 jobs
3 years ago
R&D
Pharma
Jazz loses appeal, will have patent delisted from the Orange Book
3 years ago
Pharma
Law
UK biotech hands off mid-stage C. difficile drug in up to $570M deal
3 years ago
Deals
Gay men's health group and ad agency partner say FDA blood donation proposal 'still falls short'
3 years ago
Pharma
Marketing
State attorneys general sue FDA over abortion pill access restrictions
3 years ago
R&D
Law
Activist investor pushes for management overhaul, strategic review at Theravance
3 years ago
People
EyePoint and Rallybio shake hands on collaboration; Shionogi expects billions for Covid antiviral pill — report
3 years ago
News Briefing
Tiny Apexigen to lay off majority of workers after SPAC deal
3 years ago
People
FDA neuroscience chief Billy Dunn, who led Aduhelm approval, will leave agency
3 years ago
Pharma
FDA+
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner
3 years ago
R&D
FDA+
Who’s charting paths for LGBTQ+ leaders in biopharma? Nominate them for Endpoints’ annual report
3 years ago
People
Ahead of FDA decision, Blueprint puts out full data for expanded Ayvakit label
3 years ago
R&D
Glenmark's biotech company Ichnos Sciences lays off 50
3 years ago
People
Pfizer spinout SpringWorks gets FDA priority review for lead drug
3 years ago
FDA+
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
3 years ago
Deals
Pharma
Pfizer makes moves to acquire Seagen in potential $30B+ deal
3 years ago
Deals
Pharma
Companies flail amid broad biotech fallout; Sickle cell reckoning; Follow-up on Pfizer's CRO trouble; and more
3 years ago
Weekly
European regulators recommend rejection of Merck’s Covid-19 drug molnupiravir
3 years ago
Pharma
Coronavirus
Pfizer's Paxlovid gets March FDA advisory meeting to discuss full approval
3 years ago
Pharma
Coronavirus
GSK's bellwether Zantac court date pushed to July
3 years ago
Pharma
Law
AstraZeneca pulls back the corporate curtain to highlight real people and chat complex science
3 years ago
Pharma
Marketing
First page
Previous page
370
371
372
373
374
375
376
Next page
Last page